Lv6
2608 积分 2024-12-01 加入
Adjuvant Use of Topical 0.05% Cyclosporine A in Primary Pterygium Recurrence Rate: A Systematic Review and Meta-analysis
10天前
已完结
Biomarkers in the Occurrence and Development of Pterygium
10天前
已完结
Risk factors for pterygium: Latest research progress on major pathogenesis
10天前
已完结
Pterygium: an update on pathophysiology, clinical features, and management
10天前
已完结
Simultaneous development of zanubrutinib in the USA and China
10天前
已完结
Prevalence and risk factors of pterygium: a systematic review and meta-analysis
10天前
已完结
Prevalence and associated factors for pterygium in a Chinese rural population with type 2 diabetes in a cross-sectional study: Jiangsu Diabetic Eye Disease Study (JDEDS)
10天前
已完结
Effects of chemokine receptor CCR7 in the pathophysiology and clinical features of the immuno-inflammatory response in primary pterygium
10天前
已完结
Breakthrough therapy designations in China and the United States
10天前
已完结
Initiatives to Speed New Drug Development and Regulatory Review: The Impact of FDA-Sponsor Conferences
18天前
已完结
皖公网安备34019202002308
